Search

everythinglearnresearchcommunity

for

Search:↓

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

VEGF stimulates hair cell growth and increases growth receptor levels through a specific signaling pathway.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Sebaceous glands are involved in various skin disorders, some treatable with medications like finasteride and minoxidil.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

AP-2α and AP-2β proteins are essential for healthy adult skin and hair.

The supplement highlighted advancements and challenges in plastic and reconstructive surgery, including the impact of smoking, chemotherapy, and new treatments like Tafluprost for hair loss.

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

More precise, personalized therapies are needed for autoimmune diseases.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Living with lupus as both a patient and doctor improved understanding and care for others.

Ift20 is essential for hair follicle function and skin cell movement.

STS01 1% effectively promotes hair regrowth with minimal side effects.

Hair growth is maintained by specific cell signals.

A woman experienced total hair loss after an HPV vaccine, but treatment helped regrow her hair.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Baricitinib is effective and safe for treating severe alopecia areata.

Organoids can help study COVID-19 and develop treatments, but face challenges like instability and limited renewal.

White hairs often regrow in alopecia areata patches.

Females are more affected by immune-related skin diseases, needing targeted health interventions.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Blocking Prostaglandin D₂ may help treat hair loss.

Alopecia areata cases in children are rising, especially in females and low-income regions, with a projected increase in China and decrease in the USA.

FFA has higher long-term remission rates than LPP.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.